Keyword: Advent


Baxter Sells BioPharma to Private Equity

10.05.2023 -

Confirming media reports, Baxter International announced it has agreed to sell its BioPharma Solutions (BPS) business to a private equity consortium of Warburg Pincus and...


Private Equity Steps up for Baxter Biopharma

09.05.2023 -

A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma...


Lanxess-Advent Plastics JV Launched as Envalior

04.04.2023 -

Under the name Envalior, German specialty chemicals producer Lanxess and private equity investor Advent International launched their new 40:60 joint venture for high...

Markets & Companies

Chemicals M&A Review 2022 and Outlook 2023

17.03.2023 -

2021 was historic for chemical M&As, it was a record-breaking year in terms of total value of deals. Therefore, it was expected that 2022 would only build upon this...


All Signals Point to ”Go” for new Plastics Firm

16.02.2023 -

With merger clearance granted by India this week, nothing now stands in the way of plans by German chemical producer Lanxess and private equity investor Advent...


Advent-Lanxess Materials JV Takes Shape

11.10.2022 -

The planned 60:40 specialty materials joint venture of German chemical producer and private equity group Advent International, announced at the end of May, is gradually...


Sanofi Agrees to sell Generics to Advent

12.07.2018 - French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9...


Sanofi and Advent in Talks Over Generics

18.04.2018 - French drugmaker Sanofi has confirmed market speculation that it is talking to Advent International about a sale of its European generics division, which trades as Zentiva. The...